Sabril was designated as an orphan drug by the FDA for use in treating infantilespasms.
喜保宁被FDA指定为用于治疗婴儿痉挛的稀少药品。
2
Infantilespasms in children this young are very serious and this approval provides these patients and their parents a treatment option.
儿童期的婴儿痉挛严重,这一批准使这些患者和其父母有了治疗上的选择。
3
Infantilespasms caused by risk factors for a variety of a particular syndrome, rapid brain development occurs in the special period, often with severe organic brain disease.